Skip to content
value.today

Biocon Limited vs Immunovant, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Biocon Limited and Immunovant, Inc. are worth about the same: $6.4 B and $6.6 B (market caps of Nov 20, 2026 for Biocon Limited and Oct 7, 2026 for Immunovant, Inc.).
  • Biocon Limited made a net profit of $42 M, while Immunovant, Inc. made a net loss of $506 M.
  • Biocon Limited employs more people: 12,000 against 70 at Immunovant, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

02404807209602020202120222023202420252026Biocon Limited 129Immunovant, Inc. 738

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureBiocon Limited
BIOCON.BO · #2,992 in the world
Immunovant, Inc.
IMVT · #2,921 in the world
Profile
Country🇮🇳 India🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded19782018
Size
Market cap$6.4 B$6.6 B
Revenue$1.8 B—
Net income$42 M▲ best$-506 M
Employees12,00070
Valuation
P/E ratio154×—
Price to sales3.5×—
Price to book1.6×7.8×
Free cash flow yield—-6.1%
Profitability
Return on equity—-64.8%
Altman Z-score zone——
Data as ofMarket cap Nov 2026Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Biocon Limited or Immunovant, Inc.?

Biocon Limited and Immunovant, Inc. are worth about the same: $6.4 B and $6.6 B (market caps of Nov 20, 2026 for Biocon Limited and Oct 7, 2026 for Immunovant, Inc.).

Which makes more money, Biocon Limited or Immunovant, Inc.?

Biocon Limited made a net profit of $42 M, while Immunovant, Inc. made a net loss of $506 M.

Which has more employees, Biocon Limited or Immunovant, Inc.?

Biocon Limited employs more people: 12,000 against 70 at Immunovant, Inc.